APA (7th ed.) Citation

JR, B., P, W., A, G., ESS, H., LB, B., N, B., . . . FA, G. (2025). A pathway toward clinical translation of hyperpolarized [1,4-13C2,2,3-d2]fumarate as an imaging biomarker for early cellular necrosis in vivo. Magnetic resonance in medicine, 94(3), 1202. https://doi.org/10.1002/mrm.30519

Chicago Style (17th ed.) Citation

JR, Birchall, et al. "A Pathway Toward Clinical Translation of Hyperpolarized [1,4-13C2,2,3-d2]fumarate as an Imaging Biomarker for Early Cellular Necrosis in Vivo." Magnetic Resonance in Medicine 94, no. 3 (2025): 1202. https://doi.org/10.1002/mrm.30519.

MLA (9th ed.) Citation

JR, Birchall, et al. "A Pathway Toward Clinical Translation of Hyperpolarized [1,4-13C2,2,3-d2]fumarate as an Imaging Biomarker for Early Cellular Necrosis in Vivo." Magnetic Resonance in Medicine, vol. 94, no. 3, 2025, p. 1202, https://doi.org/10.1002/mrm.30519.